School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Biomater Sci. 2020 Oct 21;8(20):5574-5582. doi: 10.1039/d0bm01265c. Epub 2020 Sep 28.
Through the utilization of hydrogen peroxide (HO) in cancer cells, nanoparticle-facilitated catalytic generation of therapeutic molecules such as O and hydroxyl radicals enabled enhanced anticancer efficacy of O or reactive oxygen species-dependent therapies. However, the intracellular HO was inadequate to obtain satisfactory therapeutic outcomes. Although several reagents such as glucose oxidase and cisplatin could promote HO levels by O conversion, HO-mediated therapeutic efficacy was still hindered in the hypoxic tumor microenvironment. Fortunately, exogenous delivery of HO or other peroxides to tumor sites was able to break the limitation of intracellular O and HO levels and enhance anti-tumor effects. In this review, we summarize the recent progress in constructing a peroxide delivery system for cancer treatments and discuss their challenges and potential applications.
通过在癌细胞中利用过氧化氢(HO),纳米颗粒促进了治疗分子如 O 和羟基自由基的催化生成,从而增强了 O 或依赖活性氧物质的治疗方法的抗癌效果。然而,细胞内的 HO 不足以获得令人满意的治疗效果。尽管一些试剂,如葡萄糖氧化酶和顺铂,可以通过 O 转化来促进 HO 水平,但在缺氧的肿瘤微环境中,HO 介导的治疗效果仍然受到阻碍。幸运的是,向肿瘤部位外源性输送 HO 或其他过氧化物能够打破细胞内 O 和 HO 水平的限制,增强抗肿瘤效果。在这篇综述中,我们总结了构建用于癌症治疗的过氧化物输送系统的最新进展,并讨论了它们的挑战和潜在应用。